Comparing medical weight loss providers
Already with a provider and wondering whether it can be cheaper? Work out below what you pay now and what it would cost with us. Underneath you will find what each provider offers and what people say about them.
Which provider are you with?
Search for your current provider
Staat je aanbieder er niet bij of wil je direct starten?
Direct aanmeldenBy provider
How we compare
We are a provider ourselves, so a comparison from us needs ground rules. These are ours.
- Only facts the provider publishes itself, with a link to the source and the date we checked it.
- Prices per dosage, as the provider shows them. No entry rates that only apply to the first month.
- No figures we make up ourselves. No grades or scores for competitors.
- We name the other side's strengths too. A comparison we always win is not a comparison.
- What a provider does not publish, we do not fill in. It says so instead.
- Spotted something wrong? Tell us and we will fix it.
Still unsure about the approach itself?
This page compares providers. Looking first for which treatment suits you, from lifestyle coaching to medication to surgery? You can read about that here.
Compare the treatment methodsBlog about medical weight loss
Read our articles about medical weight loss, lifestyle, nutrition, medication, obesity, exercise and healthy living.
Wegovy pil goedgekeurd in Europa: de eerste GLP-1 pil voor gewichtsbeheersing
De Europese Commissie heeft de Wegovy pil goedgekeurd als eerste GLP-1 pil voor gewichtsbeheersing in de EU. Wat is er precies goedgekeurd en wanneer komt de pil naar Nederland?
Orforglipron (Foundayo): wat de GLP-1-pil kan en wanneer hij hier is
De FDA keurde orforglipron op 1 april 2026 goed als Foundayo, de eerste GLP-1-pil zonder eet- of drinkvoorschriften. Wat de ATTAIN-studies laten zien, welke bijwerkingen erbij horen en wanneer het middel in Nederland te verwachten is.
Ontsteking en obesitas: waar start de vicieuze cirkel?
Een diepgaande blik op de complexe relatie tussen obesitas en chronische ontsteking, hoe ze elkaar versterken, en hoe leefstijl en nieuwe behandelingen zoals GLP-1 medicatie deze cirkel kunnen doorbreken.